Charles H. Stephens

PNP Therapeutics, Inc. operates as a biopharmaceutical company which develops a platform technology and proprietary products for the treatment of cancer. It offers E. coli purine nucleoside phosphorylase that work with nucleoside prodrugs generating active metabolites with anti-tumor activity. The company was founded by William B. Parker and Eric J. Sorscher and is headquartered in Birmingham, AL.

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Part of Thermo Fisher Scientific, Inc., T Cell Diagnostics, Inc. develops blood therapy treatments. The company is based in Cambridge, MA. T Cell Diagnostics was acquired by Endogen, Inc., a SUB of Thermo Fisher Scientific, Inc. from T Cell Sciences, Inc. on March 05, 1996 for $2.90 million.

Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL.

University of South Alabama Health System provides health care services. It comprises the University of South Alabama Medical Center and USA Knollwood Hospital. The company is headquartered in Mobile, AL.

Phase I Holdings LLC operates as a investment vehicle. The company is headquartered in DE.